Comparison of affinities of urokinase and tissue plasminogen activator for fibrin clots

Thrombosis Research
G A Homandberg, T Wai

Abstract

Affinities of low molecular weight two-chain urokinase (UK) and tissue plasminogen activator (t-PA) for fibrin clots were investigated by using clot lysis rates to estimate an affinity (Kd) between activator and fibrin clots. Lysis rates were obtained using a simple spectrophotometric based clot lysis assay which is described here. Fibrin clots, containing residual plasminogen, were suspended in a 1 ml cuvette and the increase in absorbance at 280 nm due to release of soluble fibrin peptides measured over a 150 to 250 minute time period. Lysis rates were obtained from plots of time squared vs absorbance change. Plots of activator concentration vs reciprocal rates yielded regression coefficients of 0.999 and Kd values of nM for the affinity of both activators for fibrin clots. Although both activators are known to differ in affinity for fibrin, they nonetheless had similar affinities and lysis rates for the insoluble fibrin clots. This assay also suggested possible synergism; rates over twice that expected by an additive effect were observed when the two activators were mixed at 0.3 to 7.6 nM each.

References

Sep 1, 1975·The Biochemical Journal·G L Atkins, I A Nimmo
Oct 1, 1986·Circulation·D CollenM Verstraete
Apr 1, 1987·Seminars in Thrombosis and Hemostasis·K C RobbinsM M Samama
May 15, 1985·European Journal of Biochemistry·B NorrmanM Rånby
Oct 1, 1971·Proceedings of the Society for Experimental Biology and Medicine·S M CamioloT Astrup

❮ Previous
Next ❯

Citations

May 15, 1990·Thrombosis Research·G A Homandberg, T Wai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.